Impel Pharmaceuticals Inc Stock, NASDAQ:IMPL
201 Elliott Avenue West, Suite 260, Seattle, Washington 98119
United States of America
Number of Employees: 160
Impel Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. It engages in the development and commercialization of transformative therapies for patients suffering from diseases with high unmet medical needs with an initial focus on diseases of the central nervous system. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.